CTRI/2022/11/047416
Not yet recruiting
Phase 2
A pilot study on the feasibility and efficacy of Oral Disintegration Tablet (ODT), containing polyherbal extracts, a dietary supplement in the management of Xerostomia in Head and Neck Cancer patients receiving radiation treatment
Dr Harikrishnan MD Ayu0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
- Sponsor
- Dr Harikrishnan MD Ayu
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. ECOG Performance status I and II
- •2\. Patients treated with two opposing lateral fields
- •including parotid using 2D technique
- •3\. Patients undergoing radiation or chemoradiation
Exclusion Criteria
- •1\. Lymphoma histology
- •2\. Patients undergoing re irradiation
- •3\. Patients with comorbidities
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
sing a smartphone to improve recovery and reduce the risk of postoperative pain after major orthopaedic surgery: evaluating the iCanCope Post-Op smartphone appPreoperative anxiety and postoperative pain for adolescents aged 12- 18 years undergoing surgery for limb reconstructionSurgeryISRCTN83484998ational University of Ireland, Galway60
Completed
Not Applicable
Young Adults with Paediatric-Onset Inflammatory Bowel Disease: Evaluating the Feasibility of an Optimal Health Wellbeing Intervention, After Transfer to Adult Health ServicesInflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisOral and Gastrointestinal - Inflammatory bowel diseaseOral and Gastrointestinal - Crohn's diseaseACTRN12624000751572niversity of Melbourne11
Recruiting
Phase 1
Development of new treatments for adult and chronic anorexia nervosaAnorexia NervosaAnorexia Nervosa, adult or chronic caseJPRN-jRCT1040220028Hidenori Yamasue36
Completed
Phase 2
A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergyfood allergy (cow's milk)JPRN-UMIN000018372ational Center for Child Health and Development10
Active, not recruiting
Not Applicable
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMajor Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-003359-58-GBCPS Research60